Head-to-head · Cost-Efficiency Index
Invigor Medical vs Fitstry
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invigor Medical
Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.
Visit Invigor MedicalFitstry
Cost-first shoppers who want transparent compounded semaglutide, tirzepatide or oral GLP-1 for women 40+ with a refundable $99 intake.
Visit FitstryThe verdict
Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 55. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. Fitstry still earns a C — Cost-first shoppers who want transparent compounded semaglutide, tirzepatide or oral GLP-1 for women 40+ with a refundable $99 intake.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invigor Medical | Fitstry |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 55/100 |
| Semaglutide / mo | $199/mo | $179/mo (annual plan, plus a separate fee, compounded) |
| Tirzepatide / mo | $339/mo | $269/mo (annual plan, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,148 |
| Tirzepatide / yr (modeled) | $4,068 | $3,228 |
| Coverage | Not disclosed | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank on the board | #8 | #298 |
Invigor Medical
88/100Where the value is
- Competitive mid-market pricing on both semaglutide and tirzepatide
- Long-running operator with a broad catalog that can consolidate spend
- Both molecules published up front for easy cost modeling
The tradeoffs
- Does not publish an explicit states-served list, so access is a variable in the model
- Compounded only
Fitstry
55/100Where the value is
- Transparent pricing before you commit — compounded semaglutide from $179/mo, tirzepatide from $269/mo, oral GLP-1 from $209/mo (annual plan)
- Free screening with a one-time $99 program fee that is fully refunded if a clinician can't prescribe ('Approved, or Your $99 Back')
- Monthly price bundles a lab panel (CMP, A1c, lipids, TSH), unlimited clinician access, bi-weekly care coaching and a 24/7 Care Line
The tradeoffs
- Month-to-month pricing is notably higher than the annual plan ($249 vs $179 semaglutide, $339 vs $269 tirzepatide)
- Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.